.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,984,665

« Back to Dashboard

Details for Patent: 6,984,665

Title:Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) ##STR00001## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.
Inventor(s): Blom; Taru (Nousiainen, FI), Gronroos; Paula (Turku, FI), Halonen; Kaija (Rusko, FI), Harkonen; Pirkko (Turku, FI)
Assignee: Hormos Medical Corporation (Turku, FI)
Filing Date:Jun 06, 2002
Application Number:10/162,708
Claims:1. A method for treatment or prevention of urinary symptoms related to urogenital atrophy in women, said method comprising administering to a woman an effective amount of the compound of formula (I) ##STR00004## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof wherein the urinary symptoms are micturation disorders, dysuria, hematuria, urinary frequency, sensation of urgency, urinary tract infections, urinary tract inflammation, nocturia or involuntary urinary leakage.

2. The method according to claim 1 wherein compound (I) is ospemifene.

3. The method according to claim 1 wherein compound (I), its isomer, salt or ester is administered orally, topically, transdermally, intravaginally or subcutaneously.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc